In focus · trending topic

2017 ASH ANNUAL MEETING

1 stories · following the connections

Cyclacel Pharmaceuticals Announces That Full Results From the Phase 3 Seamless Trial Have Been Selected for Oral Presentation at ASH 2017 Annual Meeting

By Nasdaq OMXNov 1, 2017, 1:02 PM UTC